Skip to content

Clinical application of botulinum toxin in dermatology

Clinical application of botulinum toxin in dermatology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030059
Enrollment
Unknown
Registered
2020-02-22
Start date
2018-01-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nodular Scabies

Interventions

Experimental group:Botox injection therapy

Sponsors

The 3rd Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with nodular scabies were diagnosed in our hospital from 2018 to 2020; the patients were male who were between 16 to 60 years old. The disease courses of these patients ranged from 4 to 24 weeks. No antibiotic administration or drug allergy history.

Exclusion criteria

Exclusion criteria: Those who are allergic to botulinum toxin; Pregnant women / breast-feeding patients

Design outcomes

Primary

MeasureTime frame
The results of ratio (%) subsidence in itching and reduction in the size of the lesion;

Countries

China

Contacts

Public ContactHu Yongxuan

The 3rd Affiliated Hospital of Southern Medical University

huyongxuan2003@163.com+86 13798082552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026